August 30, 2024Open Access
View Full PaperThe Effect of Semaglutide on Mortality and COVID-19–Related Deaths
Key Points
Key points are not available for this paper at this time.
Abstract
Patients with overweight and obesity are at increased risk of death from multiple causes, including cardiovascular (CV) death, with few therapies proven to reduce the risk.